Terms: = Bone cancer AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2 AND Prognosis
24 results:
1. The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients.
Liu B; Liu XY; Wang GP; Chen YX
Sci Rep; 2024 Mar; 14(1):5184. PubMed ID: 38431660
[TBL] [Abstract] [Full Text] [Related]
2. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
3. Diverse cell death patterns-related signature for predicting prognosis and drug sensitivity of osteosarcoma patients.
Shi Y; Wu S; Zhang X; Cao Y; Zhang L
J Gene Med; 2024 Jan; 26(1):e3613. PubMed ID: 37861176
[TBL] [Abstract] [Full Text] [Related]
4. Genetic Aspects of Conjunctival Melanoma: A Review.
Chang E; Demirci H; Demirci FY
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761808
[TBL] [Abstract] [Full Text] [Related]
5. ATRX Loss in the Development and prognosis of Conjunctival Melanoma.
van Ipenburg JA; van den Bosch QCC; Paridaens D; Dubbink HJ; Kiliç E; Naus N; Verdijk RM;
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629169
[TBL] [Abstract] [Full Text] [Related]
6. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract] [Full Text] [Related]
7. [Differential diagnostic between hepatocellular carcinoma and hepatoid carcinoma with bone metastasis revelation: What tools can be used?].
Neyrand S; Bringuier PP; Benzerdjeb N; Hervieu V; Fenouil T
Ann Pathol; 2023 Sep; 43(5):407-411. PubMed ID: 36822899
[TBL] [Abstract] [Full Text] [Related]
8. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract] [Full Text] [Related]
9. Pan-cancer analysis of tert and Validation in Osteosarcoma Cell Lines.
Xie L; Yin W; Tang F; He M
Biochem Biophys Res Commun; 2023 Jan; 639():106-116. PubMed ID: 36476950
[TBL] [Abstract] [Full Text] [Related]
10. JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Lewandowski K
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4789-4803. PubMed ID: 36242602
[TBL] [Abstract] [Full Text] [Related]
11. A genetic model for central chondrosarcoma evolution correlates with patient outcome.
Cross W; Lyskjær I; Lesluyes T; Hargreaves S; Strobl AC; Davies C; Waise S; Hames-Fathi S; Oukrif D; Ye H; Amary F; Tirabosco R; Gerrand C; Baker T; Barnes D; Steele C; Alexandrov L; Bond G; ; Cool P; Pillay N; Van Loo P; Flanagan AM
Genome Med; 2022 Aug; 14(1):99. PubMed ID: 36042521
[TBL] [Abstract] [Full Text] [Related]
12. Non-Iodine-Avid Disease Is Highly Prevalent in Distant Metastatic Differentiated Thyroid cancer With Papillary Histology.
Soe MH; Chiang JM; Flavell RR; Khanafshar E; Mendoza L; Kang H; Liu C
J Clin Endocrinol Metab; 2022 Jul; 107(8):e3206-e3216. PubMed ID: 35556126
[TBL] [Abstract] [Full Text] [Related]
13. Apoptosis-related genes-based prognostic signature for osteosarcoma.
Yang F; Zhang Y
Aging (Albany NY); 2022 May; 14(9):3813-3825. PubMed ID: 35504036
[TBL] [Abstract] [Full Text] [Related]
14. Overexpression of BAMBI and SMAD7 impacts prognosis of acute myeloid leukemia patients: A potential tert non-canonical role.
Shehata MM; Sallam AM; Naguib MG; El-Mesallamy HO
Cancer Biomark; 2021; 31(1):47-58. PubMed ID: 33780363
[TBL] [Abstract] [Full Text] [Related]
15. Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma.
Lucas CG; Grenert JP; Horvai A
Arch Pathol Lab Med; 2021 Aug; 145(8):1009-1017. PubMed ID: 33147331
[TBL] [Abstract] [Full Text] [Related]
16. Risk Stratification Using a Novel Genetic Classifier Including
Jung CK; Jung SH; Jeon S; Jeong YM; Kim Y; Lee S; Bae JS; Chung YJ
Thyroid; 2020 Nov; 30(11):1589-1600. PubMed ID: 32326836
[No Abstract] [Full Text] [Related]
17. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract] [Full Text] [Related]
18. Peculiar pathological, radiological and clinical features of skull-base de-differentiated chordomas. Results from a referral centre case-series and literature review.
Asioli S; Zoli M; Guaraldi F; Sollini G; Bacci A; Gibertoni D; Ricci C; Morandi L; Pasquini E; Righi A; Mazzatenta D
Histopathology; 2020 Apr; 76(5):731-739. PubMed ID: 31652338
[TBL] [Abstract] [Full Text] [Related]
19. Myelodysplastic syndromes and idiopathic pulmonary fibrosis: a dangerous liaison.
Papiris SA; Tsirigotis P; Kannengiesser C; Kolilekas L; Gkirkas K; Papaioannou AI; Revy P; Giouleka P; Papadaki G; Kagouridis K; Pappa V; Borie R; Boileau C; Bouros D; Crestani B; Manali ED
Respir Res; 2019 Aug; 20(1):182. PubMed ID: 31409344
[TBL] [Abstract] [Full Text] [Related]
20. Thyroid cancer bone Metastasis: Survival and Genomic Characteristics of a Large tertiary Care Cohort.
Kondraciuk JD; Rice SL; Zhou X; Gharzeddine K; Knezevic A; Spratt DE; Sabra M; Larson SM; Grewal RK; Osborne JR
Clin Nucl Med; 2019 Aug; 44(8):e465-e471. PubMed ID: 31274625
[TBL] [Abstract] [Full Text] [Related]
[Next]